Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?
Timothé MénardBjörn KoneswarakanthaDonato RoloYves BarmazLeszek PopkoRich BowlingPublished in: Drug safety (2020)